Raymond James Financial’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Raymond James Financial's VCYT Position: Q2 2026 in Review
Raymond James Financial increased its Veracyte (VCYT) stake by 28% in Q2 2026, buying an estimated $4.28M and bringing the position to 472,293 shares worth $27.7M. The position accounts for 0.01% of the portfolio, ranked #1335.
Raymond James Financial first reported a position in VCYT in Q4 2024 and has held it in 7 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Raymond James Financial held 472,293 shares of Veracyte worth $27.7M as of Q2 2026.
- Raymond James Financial bought 102,032 Veracyte shares in Q2 2026, an estimated $4.28M.
- Veracyte made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #1335 holding.
- Raymond James Financial first reported a position in Veracyte in Q4 2024 and has held it in 7 quarters since.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.